![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Fung James Lai Ching-Lung Yuen Man-Fung
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.17, Iss.10, 2008-10, pp. : 1581-1588
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug Treatment of Pediatric Chronic Hepatitis B
By Sokal E.
Pediatric Drugs, Vol. 4, Iss. 6, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
DNA vaccine: a promising new approach for chronic hepatitis B therapy
By Cova Lucyna
Future Virology, Vol. 2, Iss. 5, 2007-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Entecavir: a new treatment for chronic hepatitis B infection
By Schreibman Ian R Schiff Eugene R
Future Virology, Vol. 1, Iss. 5, 2006-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment of Chronic Hepatitis B
Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. :